Tag: IBD
Community Research Centers: A New Hope for IBD Clinical Trials
Community research centers are bringing clinical trials closer to home, potentially revolutionizing access to cutting-edge IBD treatments. This shift could eliminate geographic barriers and create more inclusive research that better reflects real-world patient experiences.
Hidden IBD Complication Nearly Kills Infliximab Patient
A Crohn’s patient on infliximab developed life-threatening complications that perfectly mimicked a simple infection, highlighting critical warning signs every IBD patient should know. This case reveals why vigilance and expert care are essential for those on immunosuppressive therapy.
New Surgery Hope for Severe Crohn’s: The ‘Bowel-First’ Breakthrough
New research reveals a breakthrough “bowel-first” surgical approach for severe Crohn’s disease that could mean safer procedures, shorter hospital stays, and better outcomes. This paradigm shift offers genuine hope for those facing the most challenging IBD complications.
Weight Gain with Crohn’s: You’re Not Alone in This Hidden Battle
Weight gain with Crohn’s disease is more common than many realize, yet it often leaves patients feeling isolated and misunderstood. From medication side effects to lifestyle changes during flares, there are multiple reasons why the scale might move upward—and you’re not alone in this struggle.
Understanding IBD: What Everyone Should Know About Crohn’s and UC
Living with IBD means facing daily uncertainty, but understanding the differences between Crohn’s disease and ulcerative colitis can help you better advocate for yourself. We break down what these conditions mean for your daily life and long-term health journey.
New At-Home Treatment for Ulcerative Colitis Gets FDA Approval
The FDA has approved Tremfya as the first fully at-home treatment option for moderate to severe ulcerative colitis. This breakthrough allows patients to start therapy with simple injections at home instead of spending hours in infusion centers.
When Your Battle Is Invisible: Understanding Life With IBD
Living with IBD means fighting a daily battle that often remains invisible to others. A recent article sheds light on the unique challenges of inflammatory bowel disease and why greater awareness matters for our community.
Breakthrough Crohn’s Treatment Targets Pain AND Scar Tissue
Palisade Bio has launched a groundbreaking clinical trial for PALI-2108, the first treatment designed to target both inflammation AND scar tissue in Crohn’s disease. This dual approach could revolutionize care for patients dealing with stricturing complications.
CHOP Research Reveals New Target for Crohn’s Treatment
Researchers at Children’s Hospital of Philadelphia have identified unique pro-inflammatory epithelial cells in pediatric Crohn’s patients, offering new hope for more targeted treatments. This cellular-level discovery could lead to therapies that address specific inflammatory pathways rather than suppressing the entire immune system.
Your Doctor Just Mentioned Biologics: What’s Next on Your IBD Journey
When your doctor suggests biologic treatment for Crohn’s disease, it can feel both hopeful and overwhelming. Here’s what this important decision means for your IBD journey and how to approach it with confidence.
